Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
The Helix Research Network (HRN) is a study aimed at understanding how our genes can influence our health and the likelihood of developing certain diseases. Researchers from various healthcare organizations are working together to gather and analyze genetic information, which may help improve medical care in the future. This trial is currently looking for participants who are at least 18 years old and are willing to follow the study guidelines.
To be part of this study, individuals must not have had certain types of transplants that could complicate their participation. If you join the study, you can expect to contribute to important research that could lead to better health outcomes for yourself and others. Your involvement will help scientists learn more about how our genetic makeup can affect our health and how this information can be used in everyday medical care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years and older
- • Willing and able to comply with all aspects of the protocol
- Exclusion Criteria:
- • History of allogenic bone marrow transplant
- • History of allogenic stem cell transplant
- • Anything that would place the individual at increased risk or preclude an individual's: 1) full compliance with study requirements; or 2) completion of the study based on the assessment from local consenting and enrolling Investigators.
About Helix, Inc
Helix, Inc. is a pioneering biotechnology company focused on advancing genomic research and personalized medicine through innovative clinical trials. With a commitment to harnessing the power of genetic data, Helix collaborates with leading research institutions and healthcare organizations to facilitate groundbreaking studies that aim to enhance patient outcomes and drive the development of targeted therapies. By leveraging state-of-the-art sequencing technology and robust data analytics, Helix strives to empower healthcare providers and patients with actionable insights, ultimately transforming the landscape of precision health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bloomington, Minnesota, United States
York, Pennsylvania, United States
Charleston, South Carolina, United States
Houston, Texas, United States
Omaha, Nebraska, United States
Bethlehem, Pennsylvania, United States
Burlington, North Carolina, United States
Sioux Falls, South Dakota, United States
Raleigh, North Carolina, United States
Columbus, Ohio, United States
Patients applied
Trial Officials
William Lee, PhD
Principal Investigator
Helix, Inc
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported